Companies: 10,795·Total market cap: $144.5T
Summit Therapeutics Inc.

Summit Therapeutics Inc.

SMMTNASDAQHealthcare● Active
$14.47
$-0.30(-2.03%)
Market Cap$11.2B
P/E Ratio
52W High$30.98
52W Low$13.83

Summit Therapeutics Inc.(SMMT)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · SMMT · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Margin %(computed)100.00%100.00%
Operating Expenses
R&D Expenses$0.54B$0.13B$0.46B$0.04B$0.06B
G&A Expenses$0.56B$0.05B$0.02B$0.02B$0.02B
Total Operating Expenses$1.09B$0.18B$0.48B$0.06B$0.07B
Operating Income($1.09B)($0.18B)($0.48B)($0.06B)($0.06B)
Operating Margin %(computed)
Interest Income$0.00B$0.01B$0.01B$0.00B$0.00B
Interest Expense$0.00B$0.01B$0.02B$0.00B$0.00B
Income Before Tax($1.08B)($0.18B)($0.48B)($0.07B)($0.07B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($1.08B)($0.18B)($0.48B)($0.07B)($0.07B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-1.44$-0.25$-0.78$-0.34$-0.71
Wtd Avg Shares0.75B0.71B0.62B0.19B0.09B
EBITDA($1.08B)($0.17B)($0.07B)($0.05B)($0.06B)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Summit Therapeutics Inc.

关于Summit Therapeutics Inc.(SMMT)损益表

Summit Therapeutics Inc.(SMMT)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,SMMT实现营收$0.00B,毛利润$0.00B(毛利率—),净利润($1.08B)(净利率—)。

常见问题

SMMT · 4 问

Summit Therapeutics Inc.(SMMT)2025财年营收为$0.00B,同比down—%。

SMMT revenueSMMT salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08